European Vaccine Initiative (EVI)

EVI seeks to support disease of poverty vaccine candidates. We act as a force to federate the major EU organisations involved in the design, development, and testing of novel vaccines. EVI also acts as a focal point for EU and global vaccine research and development activities by coordinating numerous externally funded consortia, which are working towards accelerating the development of safe, effective, and affordable vaccines

Global health,regulatory support,operational management,clinical trials,vaccines,research,network management,grant management,training,diseases of poverty,translational vaccine research,emerging diseases,malaria,leishmaniasis,diarrheal diseases,nipah virus,and zika virus

European vaccine initiative (evi) operates in the Non-profit organizations industry.

European vaccine initiative (evi)'s revenue is 11m - 100m

European vaccine initiative (evi) has 11 - 50 employees.